ArticleAnatolian journal of cardiology2018
Modeling the burden of cardiovascular disease in Turkey.
Article in Anatolian journal of cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- The economic burden of ischaemic heart diseases on health systems: a systematic review.BMJ global health · 2025Pooled it
- The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.PloS one · 2021Pooled it
- Determining the Global Economic Burden of External Health Effects of Food Consumption in 204 Countries and Territories.Nutrients · 2026Article
- Evaluation of Atherosclerotic Changes in the Superior Mesenteric Artery Using MDCT.Radiology research and practice · 2026Article
- Predicting the prevalence and estimating the economic burden of ischemic heart disease in China: Based on long short-term memory model.Medicine · 2025Article
- Estimation of economic burden of high salt intake in cardiovascular disease attributed to hypertension in Iran.Cost effectiveness and resource allocation : C/E · 2025Article
- Evaluation of the Potentially Inappropriate Cardiovascular Medication Prescription in Elderly: A Nationwide Study in Turkey.Anatolian journal of cardiology · 2023Article
- Perceived barriers to effective use of telehealth in managing the care of patients with cardiovascular diseases: a qualitative study exploring healthcare professionals' views in Jordan.BMC health services research · 2023Article
- Cardiovascular Disease in Saudi Arabia: Facts and the Way Forward.Journal of the Saudi Heart Association · 2023Review
- Economic Impacts of Cardiovascular Diseases: An Econometric Evaluation in Turkey.Iranian journal of public health · 2023Article
- Validation of MEDFICTS Dietary Assessment Questionnaire in Turkish Population.Public health nutrition · 2022Article
- Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue.Frontiers in medicine · 2022Review
- Article
- How to control the economic burden of treating cardio-cerebrovascular diseases in China? Assessment based on System of Health Accounts 2011.Journal of global health · 2020Article
- Normal coronary diameters in Turkish population.Turk gogus kalp damar cerrahisi dergisi · 2020Article
- Awareness of cardiovascular risk factors among university students in Turkey.Primary health care research & development · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey.
methodsA burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease (IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD. Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered.
resultsWe estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD. This prevalence is projected to increase to 5.4 million by 2035. The economic burden of CVD was estimated at US$10.2 billion in 2016, projected to increase twofold to US$19.4 billion by 2035.
conclusionOur study confirms that the current burden of CVD is significant, and that it is projected to increase at a steep rate over the next two decades. This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-care costs, as well as on society in the form of lost productivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.